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In the neonatal intensive care unit, the use of umbilical artery catheters (UAC) is established. Methods to
perform uninterrupted arterial blood gas and pressure monitoring, access for the delivery of ﬂuids and
medication, exchange transfusion, cardiac catheterization, and angiography using umbilical artery
catheters are used in the care of critically ill neonatal patients. One complication that can develop with
the use of UAC’s is lower limb ischemia, which can result in catastrophic effects, including limb ampu-
tation. In selected cases, conservative management may be an option in patients for limb salvage in the
setting of lower limb ischemia.
In this paper, we present a case study of a patient who developed lower limb ischemia during UAC
who was treated conservatively. This approach resulted in limb salvage and avoidance of lower extremity
amputation. The literature was reviewed for relevant risk factors and treatment options for lower limb
ischemia following umbilical artery catheterization.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Background
Umbilical artery catheters (UAC) are a useful intervention in
facilitating care for neonates with cardiopulmonary disease. The
most common usages for UAC are blood sampling and infusion of
ﬂuids and medications. With an increased use of umbilical artery
catheters, there have been notable clinical complications of its use
in the literature.1,2 These complications include thrombotic or
embolic events, hemorrhage, arterial spasm resulting in ischemia of
the lower extremities, sepsis, necrotizing enterocolitis, hyperten-
sion, congestive heart failure, visceral gangrene, aortic aneurysm,
peritoneal perforation with bleeding, spinal cord infarct and para-
plegia, foot drop, osteomyelitis, refractory hypoglycemia, ves-
icoumbilical ﬁstula, visceral herniation through the umbilical ring,
urinary ascites, vascular perforations, and death.3 Wigger suggests
that, at one time, catheter associated complications may have been
the cause of death in up to 12% of infants with umbilical artery
catheters.4 Clinicians may recognize that the visible complications
include blanching and/or cyanosis of the distal extremity or buttock
area due to vasospasm or thrombosis.5A, Boston, MA 02215, USA.
ciates Ltd. Published by Elsevier Lt1.1. Risk factors associated with complications from UAC
Both patient and catheter induced factors exist which favor the
development of thrombotic complications. Variables relating to the
patient include low ﬂow states,5 hypoxia, hyperviscous or hyper-
coaguable states, and sepsis.4 Critically ill neonates often have these
clinical conditions favoring these developments. Complications
that are associated with the catheter itself may be explained by the
method of placement and subsequent manipulation or replace-
ment of the catheter, catheter size, conﬁguration, and composition,
placement level in the aorta, use of heparin in the infusate, tonicity
and pH of infusates, and the duration of catheter use.52. Case study
A neonate was transferred to our NICU following the placement
of an umbilical artery catheter who developed a subsequent
ischemic limb episode. We review the hospital course of this
patient and pertinent literature.
This case reviewwas IRB approved for review and no conﬂicts of
interest were identiﬁed. The patient was a 2 day old neonate
transferred to Children’s Memorial Hospital for further manage-
ment following the insertion of a UAC for monitoring. Within hours
following the insertion of the catheter, the patient’s right lowerd. All rights reserved.
Fig. 2. At 3 weeks, the patient’s lower limb has improved clinically with conservative
therapy.
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external transfer, the patient’s entire lower extremity exhibited
frank deep and superﬁcial necrosis.
The patient was evaluated by the Plastic Surgery service
immediately upon transfer. Duplex ultrasound was used initially to
conﬁrm the proximal clot. Based on the senior surgeon’s experience
with ischemic lower extremity management in the pediatric pop-
ulation, aggressive conservative management was instituted which
included bedside debridement and silver sulfadiazine dressing
changes. This patient was at extremely high risk for infection and
was closely monitored for signs of sepsis and fever. Due to the
patient’s very high risk for hemorrhage, heparin or thrombolytics
were not instituted.
Over the ensuing 6 weeks, the patient’s right lower extremity
improved remarkably. Figs. 1–4 demonstrate the visible recovery of
the lower extremity. There was visible improvement of the skin/
soft tissue of the lower extremity and revascularization that was
progressive from proximal to distal. In this case, management of
this patient with conservative treatment obviated the need for
further surgical or alternate intervention. Conservative therapy
resulted in successful revascularization of the ischemic limb over
several weeks.
3. Discussion and review of literature
The literature is replete with numerous potential approaches to
management of neonatal ischemic complications of UAC place-
ment. It should be noted that Krueger et al. reported one newborn
that developed aortoiliac thrombosis and symptoms for 36 h prior
to surgical consultation and died before surgical intervention could
take place.5
3.1. Types of injuries from UAC
Iatrogenic arterial injuries account for two thirds of pediatric
arterial injuries and have been noted as a common cause of arterial
catheterization for diagnostic monitoring purposes.6 The most
common conditions requiring catheterization are respiratory
distress syndrome, asphyxia, congenital heart disease, pneumo-
thorax, sepsis, hyperbilirubinemia, and meconium aspiration.7
There have been reports regarding post mortem irreversible limb
changes, but few cases exhibit clinical reports of limb ischemia in
surviving patients. Clinicians have reported clinical complications
from UAC usage as less than 5%.8Fig. 1. Patient’s right lower extremity at presentation in the NICU.3.2. Thrombotic complications from the use of UAC
Cochran reported in 2534 catheterized infants that major
thrombotic involvement of the aorta or one of its visceral branches
was present in 13% of those autopsied but in only 2.5% of all
catheterized.9 Neal et al. performed arteriographic studies and
found thrombus formation in 95% of neonates who underwent
umbilical artery catheterization, although only 11% presented with
clinical sequelae.8 Arterial thrombosis secondary to UACmost often
involves branches of the aorta with complete thrombotic occlusion
of the aorta extremely rare.8 Catheter induced thrombosis is most
likely related to trauma as part of the Virchow’s triad of vascular
injury and altered blood ﬂow rather than length of use, but the true
nature of thrombosis in survivors is elusive. The timing and setting
in which a catheter complication is noted may affect the true
incidence of complications and may account for the discrepancy
between low clinical incidence of thrombosis and relatively high
incidence post mortem. This statistic may be related to thrombosis
from poor perfusion in the critically ill neonate resulting from
circulatory failure.10
Both patient and catheter induced factors exist which favor the
development of thrombotic complications. Variables relating to theFig. 3. At 6 weeks, the patient’s lower limb has nearly completely healed up to the
distal aspect of the metatarsal region.
Fig. 4. At 6 weeks, the patient’s lower limb has nearly completely healed up to the
distal aspect of the metatarsal region.
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coaguable states, and sepsis.4 Factors that favor thrombosis related
to the catheter itself include method of placement, subsequent
manipulation or replacement of the catheter, catheter size,
conﬁguration, and composition, placement level in the aorta, use of
heparin in the infusate, tonicity and pH of infusates, and the
duration of catheter use.5 Thrombosis due to UAC is thought to
occur both on the catheter and along the arterial wall as a result of
intimal injury caused by the catheter and infusing hypertonic
solutions through the catheter. Improvements have also beenmade
in the catheter material making them more ﬂexible (Silastic) and
less likely to contribute to thrombus formation on the catheter.2 In
order to test the effects of thrombogenic constructionmaterials and
their effect in resulting in fewer aortic clots, Jackson et al. selected
a UA catheter prototype that had heparin bonded to its poly-
urethane surface (HB-PU). The incidence of either aortic thrombosis
or complications associated with use of the HB-PU catheter was
found to be no different than in the PVC group. Platelet adhesion is
four times greater to Silastic than to polyurethane catheters in vitro,
but no difference was found with in vivo thrombus formation after
prolonged use if the catheters were of equal stiffness.11 The
thrombogenicity of catheters in prolonged use may be related to
damage to the endothelium and subsequent clot formation at the
site of intimal injury rather than clot formation on the catheter
itself.
A high incidence of complications following UACmay be present
due to small vessel caliber and the nature of the patient population
with many exhibiting decreased cardiac output, polycythemia, and
dehydration.6
Thrombosis secondary to catheter placementmay have both local
and humoral manifestations. With respect to humoral factors,
ongoing thrombosis and thrombolysis, acid–base imbalance
secondary to poor tissue perfusion, and resultant multiple organ
failure may be experienced by the patient. Blanching or mottling of
the lower extremities, difﬁculty inmaintaining a patent catheter, and
narrowing of the pulse pressure through the catheter all represent
local manifestations of possible thrombosis in the UAC. Decreasing
platelet counts and ﬁbrinogen level and elevation of ﬁbrin split
products due to localized intravascular coagulation may be seen.3.3. Catheter placement and thrombosis
Lower catheter tip placement or placement in the internal iliac
arteries is favored by Alpert due to fewer long term complications.10Catheter placement may be conﬁrmed by radiography. Careful
clinical observation and immediate catheter removal with the
institution of heparin therapy if ischemia is present are advocated
treatment guidelines. Higher volume and less morbid complica-
tions resulting from low catheter tip placement may be due to the
differences in blood ﬂow and velocity in the thoracic and abdom-
inal aorta. In three neonatal patients reported by Stringel with
major complications the catheter tip was initially in a high position
before being changed to a low position.7 Of the 32 infants with
minor complications, ﬁve tips were in the high position, six in the
intermediate position, and 21 in the low position.
The management of pediatric arterial trauma may be less
deﬁned than in adults, and the pediatric population has inherent
unique considerations. Clinicians may be reluctant to recommend
surgical intervention due simply to vessel caliber. The growth of the
limb must also be taken into consideration. Even in the absence of
symptomatic ischemia, limb growth retardation as a result of an
uncorrected circulatory impairment is not uncommon and is
reported in 14% of patients with circulation problems studied.6
3.4. Diagnosing thrombosis from UAC
The diagnosis of aortic thrombosis should be conﬁrmed in
a noninvasive manner whenever possible. Signs of aortic throm-
bosis may not be present until removal of the catheter in many
cases, and so utilizing the catheter for contrast aortography is likely
not the best option. Congenital heart disease, coarctation, or an
interrupted aortic arch should be included as part of the differential
diagnosis, and the actual malady may not be discovered until the
time of cardiac catheterization and aortography. Radionucleotide
scanning and sonography are usually sufﬁcient to conﬁrm the
diagnosis and for follow-up.
3.5. Alternatives to UAC
When analyzing the risks of UAC, Stringel notes that the safest
means of sampling blood should be used.7 Percutaneous catheters
available in small sizes in which cannulization of the radial and
posterior tibial arteries, the dorsalis pedis artery, and small
branches of the temporal arteries are all possible to use. While
these interventions are not without complications and may be
technically more difﬁcult to use, Stringel argues that they should be
used instead of UAC when possible.7 In situations when a compli-
cation is suspected, it is imperative that the catheter be removed
immediately. Stringel does not advocate the use of heparin, noting
it has not been shown to affect incidence of thrombosis or embo-
lism.7 It is stated that angiography should be performed through
the UAC before it is removed when thrombosis is suspected and
surgical consult sought.7 Peripheral venous cutdowns are safer
than UAC for infusion of medications or intravenous solutions.
When peripheral hyperalimentation is impossible, a central venous
line may be inserted. When arterial blood gases cannot be
measured percutaneously or through a capillary vessel, a periph-
eral arterial cutdown may be performed.
Heparin and percutaneous cannulization should be used
routinely, according to Flanigan, during catheterization when
possible.6 Since injuries are often detected with Doppler pressure
measurements, it is likely that complication rates are actually
higher than often reported; pressure measurements would only be
expected to detect injuries causing stenosis greater than 70%.While
there appears to be some uncertainty whether duration of catheter
use increases the risk of thrombosis, it is important to remove any
catheter not required. Five of the six limb length discrepancies that
were seen were in the nonsurgical group.6 In attempts at late
revascularization, increased growth of soft tissue was seen but no
S.J. Lin et al. / International Journal of Surgery 7 (2009) 182–186 185longitudinal bone growth after 1 year. The effect of heparin therapy
in this group was also difﬁcult to evaluate due to beneﬁts in late
results but not in 1 month following surgery.63.6. Other complications of UAC use
Acute-onset neonatal paraplegia with minimal neurologic
recovery associated with the development of progressive lower
limb deformities is another complication of UAC. These cases
represent a challenging situation and may require intervention to
treat contractures of joints of the lower extremity.3 Anterior spinal
cord infarct in neonates associated with UAC are caused by hypo-
tension, high catheter tip placement, and injection of hypertonic
solutions or blood. The areas of spinal cord infarction (anterior
thoracolumbar) correspond to the distribution of the artery of
Adamkiewicz, with sensory sparing ﬁndings.12
Ischemic, atraumatic neonatal paraplegia is a relatively rare
condition and is usually associated with prematurity, perinatal
asphyxia, or hypotension and hypothesized to be due to absence or
failure of spinal cord blood ﬂow autoregulation as a result of
prematurity and systemic hypotension.3 This failure of autor-
egulation is also consistent with skin manifestations with a similar
defect in the spinal cord vascular supply. An ischemic event asso-
ciated with a generalized vascular spasm of the vessels of the lower
limbs may release thromboxanes and other potent vasoactive
substances into the spinal cord leading to the progressive neuro-
logic damage ﬁrst noted several days later.3
Incidence of an insulin dependent mother with poor blood
glucose control whose infant developed a peroneal nerve palsy
after ischemic necrosis of the gluteal region subsequent to UAC has
been reported.13 Three of the seven infants reported by Krueger
were also born to diabetic mothers.5 Although no speciﬁc abnor-
malities have been associated with maternal disabilities, abnor-
malities of the cardiovascular system, including the development
and normal branching patterns of the umbilical vessels, frequently
are seen due to exposure of the fetus to hyperglycemia. This
anatomic ﬁnding leads to incorrect placement of the catheter
which requires removal and often replacement.13 Necrotic gluteal
region has been reported several days following replacement,
which requires surgical debridement.3.7. Lower extremity ischemia
The lower extremity can become ischemic due to acute throm-
bosis of an abdominal aortic aneurysm (AAA) in the neonatal
population.14 AAA is rare, and the recommended management of
thrombosis is in situ placement of a prosthetic graft or an extra
anatomical bypass in those patients that are at high risk. Mortality
of thrombosis of an AAA is may be related to delay in diagnosis.
Diagnosis is made by careful examination with high level of
suspicion. A CT scan of the abdominal aorta with intravenous
contrast is adequate for conﬁrming the diagnosis. Arteriogrammay
not be implemented due to potential for distal embolization.
Collateral vascular development in neonates is potentially great,
and occlusion may not cause irreversible ischemia. Fibrinolytic
therapy for acute aortic occlusion in infancy may lead to delays in
treatment. A history of UAC with acute congestive heart failure and
upper extremity hypertension is also indicative of a possible aortic
thrombosis. The differential diagnosis should include embolism,
thrombosis, and aortic coarctation with dissection. The diagnosis
can be made with Doppler ultrasound, real time B-mode ultra-
sound scans, radioisotope aortography, or contrast arteriography
via umbilical artery. None of these should delay the beginning of
surgical intervention.2Ischemic lesions on the buttocks and lower limbs in two cases
reported by Krueger required only local wound care and healed
within several weeks.5 Treatment for nerve palsy subsequent to
UAC induced vasospasm includes physiotherapy (massage, elec-
trotherapy, and strengthening exercises) and night splinting.13
3.8. Diagnostic testing and management for thrombosis from UAC
Because of the known risk of impaired limb growth, any patient
with an ischemic extremity for longer than 30 days may be studied
with serial orthoroentgenograms to assess limb growth. Flanigan
et al. established general guidelines regarding management for
these patients.6 Any patient whose lower extremity pulses
remained absent subsequent to cardiac or UAC removal or any
patient having loss of pulses for any other iatrogenic reason should
be immediately heparinized (1 mg/kg), if not contraindicated, and
observed for 6 h. If femoral pulses remain absent after 6 h of
observation, the patient is a candidate for surgery unless otherwise
contraindicated. All the surgical patients are heparinized immedi-
ately in order to decrease their likelihood of proximal and distal clot
propagation. Heparin therapy is generally continued for 24 h after
surgery. Patients with palpable femoral pulses but absent distal
pulses and Doppler evidence of impaired distal perfusion are rec-
ommended to continue heparin therapy unless anticoagulation
therapy is contraindicated.6 In patients with femoral pulse but
distal ischemia it is believed that noninvasive imaging techniques
may be useful to identify patients with common femoral artery
thrombi. Vascular surgery may be beneﬁcial in patients with
common femoral artery occlusion. Distal occlusions should prob-
ably be treated nonoperatively with continued heparin therapy. It is
imperative to weigh patient risk against risk of limb loss or limb
growth retardation and feasibility of good repair.6
Infants with mild and transient ischemia apparent by blanching
and cyanosis which resolve with catheter removal, protective
wrappings of the extremity, limb dependency, reﬂex warming, and
observationmay have no need for further intervention. Therapeutic
intravenous heparin (1 mg/kg per 24 h) should not be started until
a vascular surgery consult is obtained. The interval between cath-
eterization and ischemia is about 6 h, and so it is imperative that if
signs of ischemia do not resolve in this time, alternative, usually
surgical, approaches be taken to spare the limb and often the life of
the child.10 Amputation may often be required to spare the life of
the child subsequent to gangrenous development even after the
administration of heparin. The removal of the catheter may
aggravate ischemia and early gangrene can project a fatal prog-
nosis. If limb ischemia appears early, it is imperative that the UAC is
removed, and if placed elsewhere, done so with heparin
administration.
Alpert et al. found a 1% incidence of clinically recognized
signiﬁcant ischemia, which supports the low clinical incidence
reported by others.10 Krueger reports that seven patients of
approximately 5200 infants who had UAC in the neonatal intensive
care unit over a 10 year period were surgically managed.5 Diagnosis
was made by contrast aortography in three patients and radionu-
clide ﬂow scanning and/or sonography in the remaining patients.
Flanigan et al. report the ﬁrst attempt at surgical correction of
umbilical artery catheter induced aortic occlusion with successful
results.2 One case illustrates several treatment regimens that
should be considered with a variety of pathologies. In Flanigan’s
report, an infant had a UAC placed after which the infant began
feeding poorly. Mottling of the lower half of the body developed
along with tachypnea, and hepatomegaly, and upper extremity
hypertension. Laboratory results showed evidence of consumptive
coagulopathy with thrombocytopenia, prolonged prothrombin and
partial thromboplastin times, and the presence of ﬁbrin split
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dimensional echoaortography; however, a large mass was seen in
the abdominal aorta just below the renal arteries and extending
into the iliac arteries. The neonate was treated with a urokinase
infusion at a rate of 4000 units/kg per h for 24 h with no
improvement in clinical status, Doppler ﬂow measurements, or
echoaortographic ﬁndings. As the status worsened, surgical
thrombectomy was decided upon. After surgery, the congestive
heart failure resolved, but hypertension persisted.2
In surgical therapy for thrombus, infants typically are heparin-
ized (100 u/kg). Using a transabdominal approach, a vertical or
transverse infrarenal aortotomy is made, Fogarty catheters inser-
ted, and thrombectomy carried out both proximally and distally.
When signiﬁcant aortic wall injury has occurred, systemic utiliza-
tion of heparin may be beneﬁcial. However, due to the fact that
many newborns who are utilizing UAC also have intracranial
hemorrhage, it is imperative to weigh the risks versus the beneﬁts
of anticoagulation.
3.9. Other ischemic complications
Patients experiencing severe persistent hypertension have
thrombus involving the renal arteries. Persistent hypertension is
managed with diuretics and ﬂuid restriction to diurese the excess
volume in the extracellular space. To acutely reduce blood pressure
and/or as a second line of defense, vasodilators can be used along
with or independently from beta-blockers; hyperrenninemia
should be ruled out.5 Long term follow-up is imperative with these
patients.
Arterial occlusion can occur in children due to a variety of
sources. Nontraumatic etiologies include embolization from cardiac
sources and spontaneous arterial thrombosis secondary to dehy-
dration, polycythemia, infection, and congestive heart failure.
Traumatic arterial occlusions may be more common.
4. Conclusions
The use of the UAC for monitoring and blood sampling has
beneﬁt for the neonatal critically ill patient. However, the use of
the UAC is not without complications. Proper selection of
patients in applying invasive monitoring and diagnostics is
imperative. A threat of thrombotic induced limb ischemia can
result in limb amputation. While limb loss or even death do not
occur often, economic and emotional costs to these patients and
a limb length discrepancy in 14% of patients relate to a need for
relevant indications for invasive monitoring techniques. In ourcase study, we described a patient who was treated for limb
ischemia using a conservative approach. The result in this
patient was favorable.Conﬂict of interest
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